LOC105374660: A Potential Drug Target and Biomarker (G105374660)
![Review Report on LOC105374660 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on LOC105374660 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
LOC105374660: A Potential Drug Target and Biomarker
LOC105374660 is a protein that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. LOC105374660 has also been shown to be involved in the regulation of gene expression, which suggests that it may be a useful biomarker for certain diseases. In this article, we will explore the potential drug targeting and biomarker properties of LOC105374660.
Potential Drug Target
The identification of potential drug targets is an important step in the development of new treatments for diseases. LOC105374660 has been shown to be involved in a variety of cellular processes that are important for cancer progression, including cell adhesion, migration, and invasion. This suggests that LOC105374660 may be a useful target for drugs that are designed to inhibit these processes.
One way to identify potential drug targets is to use a database of known proteins that are involved in specific cellular processes. The Protein Data Bank (PDB) is a well-known database that contains information about proteins that have been identified as potential drug targets. The PDB contains a large collection of non-coding RNA molecules, including LOC105374660, that have been shown to be involved in various cellular processes.
In addition to its involvement in cancer progression, LOC105374660 has also been shown to be involved in the regulation of cell adhesion, which is a process that is important for the development and maintenance of tissues and organs. Many diseases, including cancer, are characterized by the breakdown of cell adhesion, which allows cells to migrate and invade surrounding tissues. LOC105374660 has been shown to play a role in the regulation of cell adhesion, which suggests that it may be a useful target for drugs that are designed to promote cell adhesion.
Biomarker
LOC105374660 has also been shown to be involved in the regulation of gene expression, which suggests that it may be a useful biomarker for certain diseases. Gene expression is the process by which a cell produces the proteins that are necessary for its proper functioning. The regulation of gene expression is an important process that helps cells to adapt to changing environmental conditions and to respond to specific stimuli.
Studies have shown that LOC105374660 plays a role in the regulation of gene expression in a variety of cell types. For example, researchers have shown that LOC105374660 can cause cells to express proteins that are involved in cell adhesion and migration. This suggests that LOC105374660 may be a useful biomarker for diseases that are characterized by the breakdown of cell adhesion, such as cancer.
Conclusion
In conclusion, LOC105374660 is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. It has also been shown to be involved in the regulation of gene expression, which suggests that it may be a useful biomarker for certain diseases. Further research is needed to fully understand the potential drug targeting and biomarker properties of LOC105374660.
Protein Name: Uncharacterized LOC105374660
The "LOC105374660 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374660 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448